To establish "Golden Sea Bream" as an acceptable market name for Stenotomus chrysops.

Summary

Prohibits the Food and Drug Administration from treating seafood from the species Stenotomus chrysops as misbranded, adulterated, or otherwise in violation of the Federal Food, Drug, and Cosmetic Act solely because it is labeled or marketed using the name "Golden Sea Bream." The effect is to authorize use of "Golden Sea Bream" as an acceptable market name and prevent FDA enforcement actions based only on that labeling choice. The provision does not change other labeling or safety requirements: FDA may still take action for other violations (for example, false claims, contamination, or other misbranding reasons).

• Authorizes the use of "Golden Sea Bream" as an acceptable market name for Stenotomus chrysops.
• Prevents FDA from deeming such food misbranded or adulterated solely because of that label or marketing.
• Does not alter other labeling, safety, or adulteration rules under the FD&C Act.
• Industry actors (fishers, processors, retailers) can use the name without fear of enforcement based only on that naming.
• FDA retains authority to act for other violations such as contamination, false claims beyond the market name, or other misbranding reasons.
• No new funding, appropriations, or implementation dates are specified.
• The protection applies only to the specified species and the specific market name.
• Could increase labeling consistency for that species but may raise consumer clarity questions about common vs. market names.